InvestSMART

Australian Clinical Labs Limited (ASX: ACL) - Announcements

Current share price for ACL : $2.825 0.045 (1.62%)+

ASX company news and announcements for Australian Clinical Labs Limited (ACL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Australian Clinical Labs Limited (ACL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Australian Clinical Labs Limited (ACL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Australian Clinical Labs Limited (ACL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$528 Suspension from Official Quotation at close of trading 14 Jun 2016 1:30PM $0.010 $2.830 risen by 28,200%
$528 Appendix 4C - Quarterly 20 Apr 2016 9:02AM $0.013 $2.830 risen by 21,669.23%
$528 Change of Company Secretary 11 Apr 2016 11:23AM $0.014 $2.830 risen by 20,114.29%
$528 Change in substantial holding 10 Mar 2016 2:45PM $0.013 $2.830 risen by 21,669.23%
$528 Becoming a substantial holder 8 Mar 2016 10:29AM $0.008 $2.830 risen by 35,275%
$528 Initial Director's Interest Notice 8 Mar 2016 8:24AM $0.008 $2.830 risen by 35,275%
$528 Non-Executive Director Appointment 7 Mar 2016 2:34PM $0.008 $2.830 risen by 35,275%
$528 Becoming a substantial holder 4 Mar 2016 4:32PM $0.008 $2.830 risen by 35,275%
$528 Ceasing to be a substantial holder from SNC 29 Feb 2016 6:37PM $0.008 $2.830 risen by 35,275%
$528 Initial Director's Interest Notice 29 Feb 2016 9:28AM $0.007 $2.830 risen by 40,328.57%
$528 Final Director's Interest Notice 29 Feb 2016 9:27AM $0.007 $2.830 risen by 40,328.57%
$528 Non-Executive Chairman appointment Non-Executive Chairman re 29 Feb 2016 8:19AM $0.007 $2.830 risen by 40,328.57%
$528 Half Yearly Report and Accounts 26 Feb 2016 2:45PM $0.007 $2.830 risen by 40,328.57%
$528 Completion of Capital Return to Shareholders 24 Feb 2016 3:38PM $0.007 $2.830 risen by 40,328.57%
$528 Change in substantial holding from SNC 3 Feb 2016 10:03AM $0.007 $2.830 risen by 40,328.57%
$528 Ceasing to be a substantial holder 2 Feb 2016 4:47PM $0.007 $2.830 risen by 40,328.57%
$528 Update - Return of Capital - ACL 28 Jan 2016 3:28PM $0.099 $2.830 risen by 2,758.59%
$528 Appendix 4C - quarterly 28 Jan 2016 3:02PM $0.099 $2.830 risen by 2,758.59%
$528 Results of Meeting 28 Jan 2016 10:59AM $0.099 $2.830 risen by 2,758.59%
$528 Return of Capital - ACL 22 Dec 2015 11:11AM $0.097 $2.830 risen by 2,817.53%
$528 Cancel - Dividend/Distribution - ACL 21 Dec 2015 2:41PM $0.097 $2.830 risen by 2,817.53%
$528 Dividend/Distribution - ACL 18 Dec 2015 8:27AM $0.095 $2.830 risen by 2,878.95%
$528 Notice of General Meeting/Proxy Form 17 Dec 2015 9:08AM $0.095 $2.830 risen by 2,878.95%
$528 General Meeting Announcement 17 Dec 2015 8:53AM $0.095 $2.830 risen by 2,878.95%
$528 ACL Receives $6.4m R&D Tax Refund 8 Dec 2015 3:50PM $0.092 $2.830 risen by 2,976.09%

751 - 775 of 1022 results

Page 31 of 41

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.